ANERO ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
ANERO ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Authorised
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type D, epsilon toxoid
Product identification
Medicine name:
ANERO ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
- Clostridium perfringens, type A, alpha toxoid
- Clostridium perfringens, type C, beta toxoid
- Clostridium perfringens, type D, epsilon toxoid
Target species:
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium perfringens, type A, alpha toxoid2.00international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type C, beta toxoid10.00international unit(s)1.00millilitre(s)
-
Clostridium perfringens, type D, epsilon toxoid5.00international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Sheep
-
Meat and offal, milk0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
- Cz Veterinaria S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 24249/09-03-2022/K-0006601
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: